Table.
IC50 (nM) | Ceritinib | Crizotinib | Alectinib |
---|---|---|---|
ALK | 0.2 | 3.0 | 1.9 |
INSR | 7.0 | 290.0 | 550.0 |
INSR IC50/ALK IC50 | 46.7 | 96.7 | 289.5 |
ALK: anaplastic lymphoma kinase, INSR: insulin receptor
Data of ceritinib and crizotinib was referred to the prescribing information of ceritinib. Data of alectinib was referred to the prescribing information of alectinib.